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Abstract 
Background: Bacillus species, possessing the methylerythritol phosphate (MEP) pathway for the synthesis of 
isoprenoid feedstock, are the highest producers of isoprene among bacteria; however, the enzyme responsible for 
isoprene synthesis has not been identified. The iron–sulfur protein IspH is the final enzyme of the MEP pathway and 
catalyses the reductive dehydration of (E)-4-hydroxy-3-methyl-2-butenyl diphosphate (HMBPP) to form isopentenyl 
diphosphate and dimethylallyl diphosphate (DMAPP). In this study, we demonstrated two unexpected promiscuous 
activities of IspH from alkaliphilic Bacillus sp. N16-5, which can produce high levels of isoprene.
Results: Bacillus sp. N16-5 IspH could catalyse the formation of isoprene from HMBPP and the conversion of DMAPP 
into a mixture of 2-methyl-2-butene and 3-methyl-1-butene. Both reactions require an electron transfer system, such 
as that used for HMBPP dehydration. Isoprene and isoamylene synthesis in Bacillus sp. N16-5 was investigated and 
the reaction system was reconstituted in vitro, including IspH, ferredoxin and ferredoxin-NADP+-reductase proteins 
and NADPH. The roles of specific IspH protein residues were also investigated by site-directed mutagenesis experi-
ments; two variants (H131N and E133Q) were found to have lost the HMBPP reductase activity but could still catalyse 
the formation of isoprene. Overexpression of IspH H131N in Bacillus sp. N16-5 resulted in a twofold enhancement of 
isoprene production, and the yield of isoprene from the strain expressing E133Q was increased 300 % compared with 
the wild-type strain.
Conclusions: IspH from Bacillus sp. N16-5 is a promiscuous enzyme that can catalyse formation of isoprene and isoa-
mylene. This enzyme, especially the H131N and E133Q variants, could be used for the production of isoprene from 
HMBPP.
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Background
Isoprene and isoamylene are important platform chemi-
cals in the synthetic chemistry industry. There are very 
few organisms which can produce isoamylene, while 
isoprene is one of the most abundant natural products 
in the environment and can be produced naturally by a 
wide variety of organisms, including animals, plants, and 
bacteria [1–3]. Isoprene production in plants has been 
well studied, and isoprene synthase (IspS) has been iden-
tified from several plants, such as kudzu and poplar [4, 
5]. The enzyme catalyses the conversion of dimethylal-
lyl diphosphate (DMAPP) to isoprene by elimination of 
pyrophosphate in a divalent cation-dependent reaction 
[6]. Bacillus species are found to be the highest produc-
ers of isoprene among bacteria [3], however, the enzyme 
responsible for isoprene synthesis has not been iden-
tified. Previous reports revealed that Bacillus subtilis 
contained an isoprene synthase activity that catalyses 
DMAPP-dependent isoprene formation, but the activity 
was very labile [7].
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There are two natural pathways for biosynthesis of 
DMAPP which is the precursor of isoprene: the meva-
lonic acid (MVA) pathway and the methylerythritol 
4-phosphate (MEP) pathway [8–11]. The last enzyme in 
the MEP pathway is 4-hydroxy-3-methyl-butenyl diphos-
phate reductase (IspH), which contains a [4Fe−4S] 
cluster with a unique fourth iron not coordinated to 
any amino acid residue and which catalyses the reduc-
tive dehydration of (E)-4-hydroxy-3-methyl-2-butenyl 
diphosphate (HMBPP) to form an approximate 5:1 mix-
ture of isopentenyl diphosphate (IPP) and DMAPP [12–
16]. This conversion is a reductive process that requires 
a special electron transport system to provide two elec-
trons to the substrate. In Escherichia coli, a system con-
sisting of NADPH, flavodoxin, and flavodoxin reductase 
has been proposed to be the natural electron source for 
IspH [14, 15, 17]. Many studies in  vitro have also dem-
onstrated that E. coli IspH catalytic activity is detected in 
the presence of this system. IspH from the malaria para-
site Plasmodium falciparum, which has no flavodoxin 
protein, uses ferredoxin (Fd) and ferredoxin-NADP+ 
reductase (FNR) as the reduction system [18].
Some substrate analogues are also converted by the 
IspH protein [19, 20]. In addition, IspH has been found 
to show acetylene hydratase activity, and catalyse the 
hydration of acetylenes to aldehydes and ketones [21]. 
These observations indicate that IspH is promiscuous in 
its catalytic activity. In this work, we revealed two further 
unexpected promiscuous reactions of IspH (Fig.  1), the 
formation of isoprene from HMBPP, and the conversion 
of DMAPP into a mixture of 2-methyl-2-butene (2M2B) 
and 3-methyl-1-butene (3M1B).
Results
Overexpression of ispH resulted in isoprene 
and isoamylene synthesis
We found that alkaliphilic Bacillus sp. N16-5 could pro-
duce a high level of isoprene; the maximum production 
reached 75  µg  L−1  OD−1 (1 OD600 of 1  L bacterial cul-
ture produce 75  µg of isoprene). To identify the gene 
responsible for isoprene biosynthesis in the strain, a fos-
mid library was constructed and screened. The isoprene 
synthase gene was not found. However, a clone strain 
produced two unknown substances and a small amount 
of isoprene compared with other clones, as determined 
by gas chromatography (GC) analysis of the headspace 
of liquid cultures (Additional file  1: Figure S1). These 
two unknown substances were identified as 2M2B and 
3M1B by GC–MS analysis (Additional file 1: Figure S2). 
After investigation of genes in DNA fragments that were 
ligated into the fosmid vector harboured by this clone, we 
concluded that the ispH gene encoding the IspH protein 
and the fer gene encoding a [4Fe−4S] type ferredoxin 
were involved in isoamylene synthesis.
Plasmid pSTV165H, encoding the Bacillus sp. N16-5 
ispH gene, and plasmid pSTV165HF, encoding the ispH 
and fer genes, were constructed and transformed into 
the E. coli strain Trans109. E. coli Trans109 containing 
pSTV165HF could produce 2M2B and 3M1B, whereas 
the strain containing pSTV165H produced little isoa-
mylene. This indicated that IspH was able to produce 
isoamylene in  vivo in the presence of ferredoxin, which 
generally functions as an electron mediator in a variety 
of metabolic processes. To test whether the IspH pro-
teins from E. coli and B. subtilis synthesised isoamylene, 
Fig. 1 The mevalonic acid (MVA) pathway and the methylerythritol 4-phosphate (MEP) pathway for isoprenoid biosynthesis and two side reactions 
by IspH
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plasmids pSTV12HF (encoding E. coli K12 ispH and 
fld) and pSTV168HF (encoding B. subtilis ispH and fer) 
were constructed and respectively transformed into 
E. coli Trans109. Both recombinant strains could pro-
duce isoamylene. The maximum production by E. coli 
containing pSTV12HF was 3.8  µg L−1  OD−1, compared 
with 7.6 µg L−1 OD−1 for E. coli containing pSTV168HF, 
and 9.2 µg L−1 OD−1 for E. coli containing pSTV165HF. 
These results indicated that the activity of IspH from dif-
ferent species might be different.
Although E. coli containing pSTV165HF could produce 
2M2B and 3M1B, Bacillus sp. N16-5 emitted little isoa-
mylene. This may be because of the low concentration 
of IspH since there is only one copy of the ispH gene on 
the chromosome. To enhance IspH expression, plasmid 
pMH was constructed, harbouring the ispH gene under 
the control of the promoter of the Bacillus sp. N16-5 
lactate dehydrogenase gene ldh, and transformed into 
Bacillus sp. N16-5. As expected, strain N16-5 containing 
the pMH plasmid produced up to 57.5  µg L−1 OD−1 of 
2M2B and 11.6 µg L−1 OD−1 of 3M1B, much more than 
the wild-type strain (Fig. 2). However, the isoprene pro-
duction of strain N16-5 remained the same. Notably, the 
ratio of 2M2B and 3M1B was approximately 5:1. Inter-
estingly, the ratio was similar to that of IPP and DMAPP 
produced by IspH.
Expression and purification of recombinant proteins
The aforementioned results implied that an unknown 
substance might be converted into isoamylene in a reac-
tion catalysed by IspH in presence of ferredoxin. To test 
this possibility, IspH protein, ferredoxin and ferredoxin-
NADP+-reductase were each expressed with a C-termi-
nal His-tag. These recombinant proteins were directly 
used for an enzyme activity assay. Notably, IspH contains 
an iron–sulfur cluster, which may be crucial for catalytic 
activity and must be assembled by special biochemical 
machinery. Therefore, to improve the production of fully 
functional IspH, we used an iron–sulfur cluster biosyn-
thesis hyperexpression strain, which has been described 
previously [15]. The purified recombinant IspH protein 
was intensely brown and appeared homogeneous after 
elution judged by sodium dodecyl sulphate (SDS) poly-
acrylamide gel electrophoresis (Fig.  3a). The absorption 
spectrum of the recombinant IspH had typical character-
istics of iron–sulfur proteins with a maximum at approxi-
mately 410 nm, a shoulder at approximately 320 nm, and 
a peak at approximately 280  nm. The ratio of E410/E280 
was 0.3 (Fig. 3b).
Isoprene and isoamylene production by IspH in vitro
To assess whether purified recombinant IspH protein 
catalyses the formation of isoamylene from its substrate, 
IspH was incubated with NADPH, Fd, and FNR, which 
might be the in vivo IspH reducing system, and each of 
three potential substrates, HMBPP, IPP and DMAPP, in 
5-mL sealed chromatography vials in anaerobic condi-
tions (Table  1). The assay mixture without recombinant 
IspH was used as a negative control. The vial headspace 
was detected by GC–MS to identify isoamylene and iso-
prene. DMAPP could be converted to 2M2B and 3M1B 
by IspH in the presence of the NADPH-Fd-FNR reduct-
ant system (Table  1). There was a small amount of iso-
prene in the headspace of the vial containing DMAPP, 
which did not increase significantly compared with the 
negative control. The product ratio of 2M2B to 3M1B 
was approximately 8.5:1, which was different from the 5:1 
ratio observed in vivo. When HMBPP was used as sub-
strate of the recombinant IspH, isoprene was, surpris-
ingly, produced in the vial headspace, while no isoprene 
was detected in the negative control. As the reaction 
proceeded, 2M2B and 3M1B were also detected in the 
headspace. We suggest that the DMAPP originating from 
HMBPP was further converted to isoamylene, but the 
isoprene in the vial headspace was directly derived from 
HMBPP by IspH. IPP was not converted to isoamylene or 
isoprene by IspH in our conditions.
A series of tests were performed in anaerobic condi-
tions to confirm that each component of the reaction sys-
tem was essential for the conversion of DMAPP/HMBPP 
(Additional file  1: Table S1). The results demonstrated 
that the recombinant IspH protein that catalysed the for-
mation of isoamylene and isoprene required ferredoxin 
and FNR proteins in addition to NADPH as a cofactor. 
Bacillus sp. N16-5 has a flavodoxin that might be another 
mobile electron carrier; however, when it was substituted 
for Fd in the test, DMAPP and HMBPP could not be con-
verted to isoamylene and isoprene by IspH. The addition 
Fig. 2 GC profile of headspace of Bacillus sp. N16-5 (wild-type) and 
engineered strain N16-5 containing the pMH plasmid with ispH gene 
after incubation at 37 °C for 12 h. The retention times of 3M1B, 2M2B 
and isoprene are 4.5, 5.5 and 11.3 min, respectively
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of Mg2+ was not required for IspH activity in isoamylene 
and isoprene synthesis. To determine the kinetic param-
eters, IspH activity toward DMAPP was measured with 
DMAPP concentrations from 0.1 to 1  mM (Additional 
file  1: Figure S3). Based on Michaelis–Menten and 
Lineweaver–Burk plots, the DMAPP KM was calculated 
to be approximately 275 µM. The maximal catalytic activ-
ity was approximately 6.2 nmol min−1 mg−1. It was dif-
ficult to determine the activity of IspH with HMBPP for 
isoprene formation because HMBPP was mostly trans-
formed into IPP and DMAPP, and the latter could be 
further converted to isoamylene by IspH. In our test, the 
maximal activity obtained for the formation of isoprene 
from HMBPP was 2.9 nmol min−1 mg−1 in the presence 
of the NADPH-Fd-FNR reductant system. The recom-
binant IspH could also use reduced methyl viologen as 
an artificial electron donor, and the activity of IspH for 
isoprene formation was 3.5  nmol  min−1 mg−1, slightly 
higher than that of IspH using its putative natural reduc-
ing system.
Enzymatic activity assays in D2O
To investigate proton transfer in these two reactions cat-
alysed by IspH, enzymatic activity assays were performed 
in 80  % (v/v) D2O buffer and the products were identi-
fied by GC–MS. Protons are likely to derive from the 
bulk water of the reaction system; if the reaction is per-
formed in D2O buffer, the molecular weight of the prod-
ucts of IspH would be increased, and the major peaks in 
the mass spectra would differ from those in H2O buffer. 
As expected, the mass spectrum showed that the ratios 
of fragment ions 71/70 and 56/55 of 2M2B produced by 
IspH in D2O buffer were significantly enhanced com-
pared with the results in H2O buffer (Fig.  4); this fact 
suggested that the pyrophosphate group of DMAPP was 
eliminated and a proton from the bulk water could be 
used to form deuterium-2M2B. However, the abundance 
of fragment ion 70 was still greater than that of 71 in the 
mass spectrum, which was not consistent with the pre-
diction based on the H2O/D2O ratio (1:4). In contrast to 
isoamylene, the mass spectrum of isoprene produced by 
IspH in D2O buffer remained unchanged, which demon-
strated that C4 and C1 of HMBPP did not accept a pro-
ton after loss of the hydroxyl and pyrophosphate groups.
Role of ferredoxin and flavodoxin in isoamylene 
and isoprene synthesis in vivo
Bacillus sp. N16-5 has one [4Fe−4S] type ferredoxin and 
one flavodoxin. To evaluate whether they are required 
Fig. 3 SDS polyacrylamide gel electrophoresis and UV–Vis spectrum of recombinant IspH protein. a SDS-PAGE: Lane M, molecular weight markers; 
lane 1, FNR protein; lane 2, IspH; lane 3, ferredoxin. b UV–Vis spectrum of recombinant IspH (1.5 mg mL−1) recorded in 20 mM Tris–HCl, pH 7.8. The 
spectrum shows a maximum at 410 nm and a shoulder at 320, indicating the presence of an iron–sulphur cluster
Table 1 Enzyme tests with IspH
Values are presented as the average ± standard deviation of three independent 
experiments
The reaction was performed in 20 mM Tris–HCl buffer (pH 7.8) containing 
150 mM NaCl at 37 °C for 1 h
a Trace amount of isoprene, as was also observed in the negative control
Substrate Products in the headspace (ng/mL) [2M2B]:[3M1B]
Isoprene 2M2B 3M1B
DMAPP +a 39.1 ± 3.9 4.58 ± 0.6 8.5:1
IPP – – –
HMBPP 21.6 ± 2.3 6.23 ± 1.1 0.83 ± 0.1 7.5:1
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for isoamylene and isoprene synthesis in  vivo, we con-
structed strain N165D1, which is a fer (ferredoxin) gene 
knockout, and strain N165D2, which is a fld (flavodoxin) 
gene knockout. Both mutant strains grew almost nor-
mally in Horikoshi-I medium (Fig.  5a). This result sug-
gests that ferredoxin and flavodoxin are not essential 
for IspH activity in Bacillus sp. N16-5, which utilises 
the MEP isoprenoid biosynthesis pathway to produce 
IPP and DMAPP, two universal precursors of terpenes. 
However, the production of isoprene emitted by strain 
N165D1 was reduced by approximately 50  % compared 
with the wild-type strain. In contrast, isoprene produc-
tion by strain N165D2 was close to that of the wild-type 
strain (Fig. 5b). Because IspH overexpression in Bacillus 
sp. N16-5 resulted in much more isoamylene produc-
tion (see above), plasmid pMH, containing the ispH gene, 
was transformed into the mutant strains N165D1 and 
N165D2. Strain N165D1 harbouring pMH produced little 
isoamylene, while strain N165D2 harbouring pMH pro-
duced 32  µg L−1 OD−1 isoamylene, which was approxi-
mately half the level of the wild-type strain harbouring 
pMH (Fig.  5c). These results indicated that the absence 
Fig. 4 Mass spectrum of isoamylene. a Mass spectrum of 2M2B 
produced by the reaction that was performed in H2O buffer. b Mass 
spectrum of 2M2B produced by the reaction that was performed in 
80 % (v/v) D2O buffer
Fig. 5 Growth phenotype and isoprene and isoamylene production by Bacillus sp. N16-5 and its derivatives. a Bacillus sp. N16-5 (wild-type), 
N165D1 (Δfer) and N165D2 (Δfld) strains were grown in Horikoshi-I medium at 37 °C on a rotary shaker at 220 rpm. b Isoprene production by these 
strains. c Isoamylene production by these strains when containing pMK4 or pMH plasmid with ispH gene. Error bars represent the standard devia-
tions of three replicates
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of ferredoxin not only reduced isoprene production by 
half but nearly blocked isoamylene synthesis in Bacillus 
sp. N16-5. Combined with our in vitro enzymatic activity 
assay results, these findings demonstrate that ferredoxin 
is more efficient than flavodoxin as an electron donor to 
IspH in Bacillus sp. N16-5.
The roles of IspH protein residues in the promiscuous 
activities
Based on previous reports, there are several highly con-
served amino acid residues that contribute to IspH activ-
ity toward HMBPP [22–25]. To investigate the roles 
of these conserved amino acids in the promiscuous 
activities of IspH, the corresponding IspH variants were 
constructed. As described above, E. coli Trans109 har-
bouring plasmid pSTV165HF, used for coexpression of 
the Bacillus sp. N16-5 ispH and fer genes, could produce 
isoamylene and isoprene; therefore, IspH variants activ-
ity could be determined by quantitative analysis of isoa-
mylene and isoprene produced by recombinant strains 
containing protein variants. Replacement of the strictly 
conserved His131 (H124 in E. coli IspH) by Asn, or 
Glu133 (E126 in E. coli IspH) by Gln, led to loss of isoa-
mylene synthesis activity (Additional file  1: Figure S4), 
but both IspH variants could still produce isoprene.
For confirmation of these results, in  vitro enzymatic 
activity assays were performed in anaerobic conditions. 
The H131N and E133Q IspH variant proteins were 
expressed and purified. The purified recombinant IspH 
variants were incubated with DMAPP or HMBPP in 
the presence of the NADPH-Fd-FNR reductant system 
in 5-mL sealed chromatography vials. DMAPP was not 
converted to isoamylene by either the H131N or E133Q 
IspH variant proteins, however, both could catalyse the 
formation of isoprene from HMBPP; the maximal activi-
ties of the H131N and E133Q IspH variant proteins were 
2.5 and 3.1 nmol min−1 mg−1, respectively. It was notable 
that IspH H131 and E133 are strictly conserved and play 
a crucial role in the activity toward HMBPP [23, 24, 26]. 
To examine whether the H131N and E133Q IspH vari-
ant proteins could catalyse the transformation of HMBPP 
into DMAPP and IPP, their reaction products were ana-
lysed by an acid hydrolysis method, as described in pre-
vious reports [27, 28]. The two variant proteins lost the 
HMBPP reductase activity, which was consistent with 
previous reports [23, 25]. As a consequence, the H131N 
or E133Q IspH variants could be seen as isoprene syn-
thases specialized for the conversion of HMBPP into 
isoprene.
To further investigate the activities of the H131N and 
E133Q IspH variants in Bacillus sp. N16-5, the corre-
sponding pMH variants were obtained by site-directed 
mutagenesis and transformed into Bacillus sp. N16-5 to 
construct strains BSH131N and BSE133Q, respectively. 
After analysis of the headspace of cultures of these bac-
teria by GC–MS, we found that isoprene production by 
strain BSH131N was increased to three times the level of 
that by the wild-type strain, i.e. up to 235 µg L−1 OD−1; 
isoprene emitted by the BSE133Q strain reached approxi-
mately 352 µg L−1 OD−1 (Fig. 6). Neither strain emitted 
isoamylene. These results suggest that the H131  N and 
E133Q IspH variant proteins can be used for isoprene 
production.
Discussion
Over the years, IspH, the last enzyme in the MEP path-
way, has received considerable attention because it is not 
present in humans but is essential for microorganisms 
and thus is a viable target for the development of new 
antimicrobial drugs [29–31]. The structure and reaction 
mechanisms of IspH have been extensively studied. Based 
on previous reports, IspH shows promiscuous activ-
ity toward acetylenes. It can convert but-3-ynyl diphos-
phate and pent-4-ynyl diphosphate into an aldehyde and 
a ketone respectively [21]. In the present work, we have 
determined that IspH catalyses two unexpected side 
reactions in addition to its main catalytic activity. One is 
the elimination of DMAPP pyrophosphate to form 2M2B 
and 3M1B. The ratio of the two isoamylenes produced by 
Bacillus sp. N16-5 IspH in  vivo was approximately 5:1, 
while in in vitro enzymatic activity assays, the ratio was 
approximately 8.5:1. Interestingly, E. coli IspH also pro-
duced isoamylenes, but the in  vivo assay demonstrated 
a 2M2B:3M1B ratio of approximately 1.5:1 (Additional 
file 1: Figure S5). The other side reaction is the formation 
of isoprene from HMBPP, which is used as substrate to 
produce IPP and DMAPP by IspH in the MEP pathway. 
Fig. 6 Isoprene production by Bacillus sp. N16-5 strains. Error bars 
represent the standard deviations of three replicates
Page 7 of 11Ge et al. Microb Cell Fact  (2016) 15:79 
To some extent, isoprene can be seen as a byproduct 
generated by IspH in the process of transformation of 
HMBPP into IPP and DMAPP.
The basis of these two reactions is that the pyrophos-
phate group of HMBPP or DMAPP can be eliminated by 
IspH. In fact, for HMBPP, PPi is a better leaving group 
than an OH moiety, but conformational restrictions at 
the active site of IspH favour the OH group as the leaving 
group instead of pyrophosphate at the C1 position [23]. 
However, the formation of isoprene from HMBPP indi-
cates that PPi can be still removed with low activity by 
IspH. When the hydroxyl and pyrophosphate groups are 
all eliminated, the allyl intermediate forms, which would 
transform into isoprene instead of being protonated 
at the C1 and C4 positions; this proposed mechanism 
is supported by the data obtained in enzymatic activity 
assays in D2O buffer. In contrast, the formation of isoa-
mylene from DMAPP would involve the introduction of a 
proton after the removal of PPi. Whether the isoamylene 
formed was 2M2B or 3M1B depends on the position of 
protonation (C1 or C3). Obviously, based on the product 
ratio of 2M2B to 3M1B, the protonation preferentially 
occurs at the C1 position. Based on our results, the two 
unexpected reactions catalysed by IspH are reductive 
processes requiring an electron transfer system. Their 
potential catalytic mechanisms are shown in Fig. 7. Iso-
prene formation from HMBPP may include dehydroxyla-
tion leading to an allyl radical intermediate, followed by 
the elimination of pyrophosphate and the formation of 
isoprene (Fig.  7a). Isoamylene formation from DMAPP 
may include the elimination of pyrophosphate lead-
ing to an allyl anion intermediate, which is protonated 
either at C1 or C3 to form 2M2B or 3M1B (Fig. 7b). The 
strictly conserved amino acids His131 and Glu133 of 
IspH may play crucial roles in the protonation, a conclu-
sion supported by the fact that the H131N and E133Q 
IspH mutants could catalyse the elimination of both the 
hydroxyl and pyrophosphate groups of HMBPP to form 
isoprene, but could not catalyse isoamylene formation 
which involves the protonation step. Further studies 
are required to explore the catalytic mechanisms of the 
unexpected promiscuous activities.
Isoprene synthase (IspS) is the enzyme responsible 
for isoprene biosynthesis in plants. This enzyme cataly-
ses the formation of isoprene by elimination of pyroph-
osphate from DMAPP. A number of studies of IspS for 
isoprene production have been reported [32–34]. Here 
we demonstrated that IspH, especially the H131N and 
E133Q variants, could be used for isoprene production. 
IspH uses HMBPP as substrate to form isoprene, which 
has two advantages over IspS. First, the accumulation 
of prenyl diphosphate can be avoided in the host cell. 
In previous study [35], prenyl diphosphate toxicity was 
observed in E. coli expressing a heterologous MVA path-
way. Similarly, cytotoxicity related to prenyl diphosphate 
accumulation was reported in B. subtilis [36]. Second, the 
number of enzymatic reactions for isoprene production 
can be reduced because HMBPP can be directly con-
verted into isoprene.
To date, the enzyme responsible for isoprene synthe-
sis in bacteria, especially the Bacillus species which can 
produce more isoprene than others, has not been iden-
tified. Many attempts have been made to isolate IspS 
from B. subtilis, but without success [7, 37]. In this study, 
IspH was serendipitously found to catalyse the forma-
tion of isoprene from HMBPP. It is probable that IspH is 
Fig. 7 Potential mechanisms of isoprene and isoamylene formation by IspH. a Isoprene from HMBPP; b Isoamylene from DMAPP
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responsible for isoprene production by bacteria. Isoprene 
may be a byproduct of IspH in the process of the trans-
formation of HMBPP into IPP and DMAPP. Although, 
our results clearly demonstrate that IspH can catalyse 
isoprene formation from HMBPP, the existence of a spe-
cialized enzyme for isoprene synthesis in Bacillus sp. 
N16-5 cannot be ruled out. To investigate this question, 
we have attempted to disrupt the ispH gene in Bacillus 
sp. N16-5 in the presence of the MVA pathway from 
Enterococcus faecalis, but without success.
Conclusions
We have revealed two unexpected side reactions of IspH 
for the first time. These new discoveries provide important 
insight into the IspH protein, which is a putative target 
for antimicrobial drugs for the treatment of malaria and 
tuberculosis. IspH, especially the H131 N and E133Q IspH 
variants can catalyse isoprene formation from HMBPP, 
which may be a good alternative to IspS from plants for 
isoprene production. In addition, it is most probable that 
the promiscuous activity of IspH is the cause of isoprene 
production by bacteria. More details of the promiscuous 
activity of IspH will be investigated in future study.
Methods
Bacterial strains and culture conditions
The bacterial strains and plasmids used in this study are 
listed in Additional file  1: Table S2. E. coli strains were 
routinely grown in Luria–Bertani (LB) broth at 37 °C on 
a rotary shaker at 220 rpm. For general purposes, Bacil-
lus sp. N16-5 and its derivatives were grown aerobically 
in Horikoshi-I medium with 2 % NaCl (pH 10.0). To con-
struct mutant strains, Bacillus sp. N16-5 and its deriva-
tives were grown in complex neutral medium (NCM) 
(pH 7.7) or SA5 agar medium [38]. When necessary, 
antibiotics were added to the growth media at the follow-
ing concentrations: ampicillin, 100 µg mL−1; kanamycin, 
50  µg  mL−1; chloramphenicol, 12.5  µg  mL−1. For selec-
tion of Bacillus sp. N16-5 transformants, the final antibi-
otic concentrations were chloramphenicol at 2.5 µg mL−1 
and erythromycin at 1 µg mL−1 in NCM or SA5 medium.
Qualitative and quantitative analysis of isoamylene 
and isoprene
For identification of isoamylene, a gas chromatography-
mass spectrometry (GC–MS) method was established as 
follows. An Agilent Technologies 7890B GC/5977A MSD 
that was equipped with an Agilent HP-PLOT Al2O3/S GC 
Column (25 m, 0.32 mm, 8.00 µm, 7-in. cage) with parti-
cle traps was used. Helium was used as the carrier gas at 
a flow rate of 2 mL min−1. The oven was kept at a con-
stant temperature of 110 °C. To identify isoamylene pro-
duction, peak retention times and mass spectra obtained 
from the bacterial headspace were compared with the 
retention time and mass spectrum of 2M2B and 3M1B 
standards (Sigma, St.Louis,MO, USA). For quantitative 
analysis of isoamylene production, bacterial strains were 
inoculated into headspace vials with Teflon-lined silicone 
septa at an inoculum concentration of 2 % and grown for 
12 h at 37  °C on a rotary shaker at 220  rpm. The head-
space of the medium was used as a negative control. A 
volume of 1 mL of headspace was sampled using a gas-
tight syringe (SGE, Melbourne, Australia) and injected 
into the GC7800 GC inlet port (PuRui Instrument, Bei-
jing, China), which had been equipped with a flame 
ionisation detector. The peak area was converted to isoa-
mylene or isoprene concentration by comparing it with a 
standard curve that was plotted with a set of known con-
centrations of isoamylene or isoprene.
Coexpression of ispH with fer in E. coli
For coexpression of the Bacillus sp. N16-5 ispH and fer 
genes, the plasmid pSTV165HF was constructed as fol-
lows. The complete ispH gene was amplified by PCR, and 
the product was cloned into vector pSTV28 (TaKaRa, 
Shiga, Japan) between HindIII and BamHI sites, generat-
ing the plasmid pSTV165H. The fer gene was fused with 
the Plac promoter and then ligated into pSTV165H at the 
EcoRI and BamHI sites, to generate plasmid pSTV165HF. 
For coexpression of the ispH gene of B. subtilis 168 with 
the corresponding ferredoxin and the ispH gene of E. coli 
K12 with the corresponding flavodoxin, plasmids pST-
V168HF and pSTV12HF were constructed as described 
above. These three constructs were transformed into E. 
coli strain Trans109, and transformants were selected on 
LB agar supplemented with 25 µg mL−1 chloramphenicol.
Construction of mutant strains
To construct Bacillus sp. N16-5 mutant strains and the 
plasmids pND1 and pND2, derivations of the shuttle vec-
tor pNNB194 [39] were used as gene deletion constructs. 
Each plasmid, which contained approximately 1.6  kb of 
DNA homologous to the deletion-flanking region, was 
constructed as follows. Two sets of primers (Additional 
file 1: Table S3) were designed; one set amplified an 800-
bp upstream fragment, which contained the 5ʹ region of 
each gene to be deleted, and the other amplified 800-bp of 
a downstream fragment, which contained the 3ʹ region of 
the target gene. The two fragments were fused together by 
overlap extension PCR, and the product was digested with 
EcoRI and BamHI (NEB, Ipswich, USA) and ligated into the 
shuttle vector pNNB194, which had already been digested 
with the same enzymes. Finally, plasmids pND1 and pND2 
were obtained. The deletion plasmids were transformed 
into Bacillus sp. N16-5 using the protoplast transformation 
procedure that was developed by Chenghua Gao [38], and 
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transformants were selected on SA5 agar plates that had 
been supplemented with 1 µg mL−1 erythromycin at 34 °C. 
A single transformant was then inoculated into NCM 
medium, followed by double crossover and selection for 
the loss of the target gene from its locus. The final mutant 
clones were confirmed by PCR.
Overexpression of ispH in Bacillus sp. N16‑5
Plasmid pMH, which was used for ispH overexpression 
in Bacillus sp. N16-5 and its derivatives, was constructed 
as follows. The ispH gene was amplified by PCR with the 
primers listed in Additional file 1: Table S1 using N16-5 
strain genomic DNA as the template. The PCR products 
were fused with the native  Bacillus  sp. N16-5 ldh  pro-
moter by overlap PCR, digested with EcoRI and BamHI 
(NEB), and ligated into the corresponding site of the 
shuttle vector pMK4 [40] to create pMH. This plasmid 
with the ispH gene under transcriptional control of the 
Pldh promoter was then transformed into Bacillus sp. 
N16-5 and the corresponding mutant strains using a pro-
toplast transformation method [38].
Expression and purification of recombinant proteins
For expression of IspH, ferredoxin and ferredoxin-
NADP+-reductase from Bacillus sp. N16-5, their open 
reading frames were amplified by PCR, and the ampli-
fied fragments were cloned into the NcoI/XhoI sites of 
pET-28a(+) (TaKaRa, Shiga, Japan) to yield pET-ispH, 
pET-fer and pET-fnr, respectively, followed by transfor-
mation into E. coli BL21 (DE3) cells. To improve IspH 
protein-specific activity, a ispH hyperexpression strain 
was constructed using the method of Gräwert et al. [15]. 
Part of the isc operon from E. coli was amplified by PCR 
using high-fidelity DNA polymerase. The products were 
digested with KpnI and PstI and then ligated into the cor-
responding site of vector pSTV28 (TaKaRa, Shiga, Japan). 
The resulting plasmid pST-isc was transformed into 
E. coli BL21 (DE3) harbouring the pET-ispH plasmid. 
The recombinant strain was grown in LB medium sup-
plemented with kanamycin (50  µg  mL−1) and chloram-
phenicol (25 µg mL−1) at 37 °C. When the OD600 reached 
approximately 0.6, cysteine (1  mM), FeCl3 (0.1  mM) 
and IPTG (0.1  mM) were added to the culture, which 
was then incubated for 16 h at 18 °C on a rotary shaker 
at 110  rpm. The cells were harvested by centrifugation, 
washed twice with ddH2O, and stored at −80 °C.
Purification of recombinant proteins was performed in 
anaerobic conditions in a glovebox (Shel Lab, Cornelius, 
Oregon, USA) that had been flushed with a gas mixture of 
95 % N2 and 5 % H2. Residual O2 was removed with pal-
ladium catalysts. Buffers were equilibrated overnight in 
the tent under stirring and were degassed by ultrasound 
before use. The harvested cells were resuspended and 
lysed in BugBuster Protein Extraction Reagent (Merck, 
Darmstadt, Germany) by pipetting or gentle vortexing 
for 20 min at room temperature and then centrifuged at 
16,000×g for 20 min at 4 °C. The supernatant was applied 
to a Ni–NTA column that had been equilibrated with 
20 mM Tris–HCl, pH 7.8, containing 5 mM imidazole and 
150 mM NaCl. After washing with 20 mM imidazole, pro-
tein was eluted with 250  mM imidazole. Fractions were 
collected and desalted with a desalting column (Sangon 
Biotech, Shanghai, China). The purified protein was flash-
frozen in liquid nitrogen and stored at −80 °C until use.
Enzymatic activity assays
Enzyme-catalysed reactions were performed in 5-mL 
sealed chromatography vials in anaerobic conditions 
in a glovebox. Assay mixtures contained 150  mM NaCl, 
20 mM Tris–HCl (pH 7.8), 2 mM DTT, 1 mM NADPH, 
1 mM DMAPP (unless otherwise stated), 20 µM Fd, 5 µM 
FNR and 0.5 µM IspH. The total volume was 500 µL. To 
test the IspH protein substrate, DMAPP in the mixtures 
was replaced with IPP or HMBPP. After the mixtures were 
ready, the vial was immediately sealed and incubated at 
37 °C for 1 h. Headspace gas (1 mL) was sampled with a 
needle and syringe. Headspace of the mixtures with no 
substrate was run as a negative control. To avoid creating 
a vacuum in the vial, 1 mL water was injected into the vial 
concurrent with the removal of the headspace.
Site‑directed mutagenesis
To investigate the roles of specific protein residues in cat-
alytic activity, site-directed mutagenesis was performed 
using mismatch PCR as follows. The entire pSTV165HF 
plasmid was amplified by PCR using high-fidelity DNA 
polymerase with mutagenic primers. The amplification 
products were digested with DpnI for 2  h at 37  °C and 
then transformed into competent E. coli strain DMT 
(TransGene Biotech, Beijing, China). Transformants 
were selected on LB-agar plates supplemented with 
25  µg  mL−1 erythromycin, and the final mutant clones 
were confirmed by sequencing. The mutant plasmids 
were extracted and transformed into E. coli Trans109.
Additional file
Additional file 1. This file consists of five supplemental figures and 
three supplemental tables. Figure S1 and Figure S2 present additional 
information on identification of 3-methyl-1-butene, 2-methyl-2-butene 
and isoprene. Table S1 presents isoamylene and isoprene production in 
various conditions. Figure S3 presents Michaelis–Menten plots of the 
activity of recombinant IspH toward DMAPP. Figure S4 shows isoamylene 
production by recombinant strains expressing IspH variants. Figure 
S5 presents GC profile of 3-methyl-1-butene and 2-methyl-2-butene 
produced. Table S2 and Table S3 list strains, plasmids and primers used 
in this study.
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